PS1527 HYDROXYUREA ESCALATED TO MAXIMAL TOLERATED DOSE IN CHILDREN WITH SICKLE CELL ANEMIA AND BCL11A: BENEFITS FOR END-ORGAN DAMAGE AND ACUTE COMPLICATIONS UP TO 6 YEARS OF AGE
HemaSphere(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HemaSphere(2019)